← All stocks

BioXcel Therapeutics, Inc.

BTAI Net selling
CIK 0001720893 #4965 in the set updated 17 Sep 2026
Bought (120 mo)
$321.11K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$75.03M
$447.41K on a plan · $12.63M straight out of an exercise
Sold at will
$61.95M
23 of 106 sales
Net
−$74.70M
−$61.63M against sales at will

By person

11 insiders · 149 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Mehta Vimal
CEO and President
$89.34K (21)
$18.86M (30)
−$18.77M
25,484,068
$27.70M
−7.8%
Nandabalan Krishnan
Director
$4.92K (1)
$17.85M (8)
−$17.84M
17,727,750
$19.27M
−4.6%
BioXcel Holdings, Inc. entity
10% owner
$14.59M (1)
−$14.59M
17,566,750
$19.10M
−3.5%
BioXcel LLC entity
10% owner
$14.59M (1)
−$14.59M
8,546,750
$9.29M
−6.9%
O'Neill Vincent
See Remarks
$4.82M (21) scheduled
−$4.82M
19,957
$21.69K
Yocca Frank
Chief Scientific Officer
$66.31K (5)
$3.85M (22)
−$3.79M
26,210
$28.49K
Steinhart Richard I
Chief Financial Officer
$7.60K (3)
$372.18K (10) scheduled
−$364.58K
26,335
$28.63K
MUELLER PETER
Director
$152.94K (12)
+$152.94K
258,320
$280.79K
+9.7%
Rodriguez Javier
See Remarks
$81.81K (9) scheduled
−$81.81K
26,838
$29.17K
Wiley Matthew T.
See Remarks
$6.56K (4) scheduled
−$6.56K
19,011
$20.66K
+1,801%
MACK DAVID J.
Director
20,317
$22.08K

No percentages here. This company's share count has moved by a factor of 7.8 over the window, from 5,486,038 to 42,748,364 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Mehta Vimal
16 Jun 2023
CEO and President
Sold after exercise
747
$21.89
$16.35K
Mehta Vimal
16 Jun 2023
CEO and President
Sold after exercise
4,266
$20.90
$89.16K
Mehta Vimal
16 Jun 2023
CEO and President
Sold after exercise
24,987
$20.01
$499.99K
Mehta Vimal
15 Jun 2023
CEO and President
Sold after exercise
8,012
$21.90
$175.46K
Mehta Vimal
15 Jun 2023
CEO and President
Sold after exercise
21,988
$21.41
$470.76K
Nandabalan Krishnan
6 Apr 2023
Director
Sold after exercise
60,000
$17.32
$1.04M
Mehta Vimal
21 Mar 2023
CEO and President
Sold after exercise
900
$20.15
$18.14K
Mehta Vimal
21 Mar 2023
CEO and President
Sold after exercise
29,100
$19.70
$573.27K
Mehta Vimal
20 Mar 2023
CEO and President
Sold after exercise
604
$18.88
$11.40K
Mehta Vimal
20 Mar 2023
CEO and President
Sold after exercise
3,896
$18.22
$70.99K
Mehta Vimal
20 Mar 2023
CEO and President
Sold after exercise
5,333
$18.86
$100.58K
Mehta Vimal
20 Mar 2023
CEO and President
Sold after exercise
24,667
$18.20
$448.94K
O'Neill Vincent
20 Jan 2023
Chief Medical Officer
Sold after exercise
29,713
$30.00
$891.39K
Nandabalan Krishnan
5 Jan 2023
Director
Sold after exercise
800
$22.93
$18.34K
Nandabalan Krishnan
5 Jan 2023
Director
Sold after exercise
25,089
$22.32
$559.99K
Nandabalan Krishnan
4 Jan 2023
Director
Sold after exercise
9,821
$22.21
$218.12K
Nandabalan Krishnan
4 Jan 2023
Director
Sold after exercise
24,290
$21.59
$524.42K
Mehta Vimal
16 Dec 2022
CEO and President
Sold after exercise
9,887
$19.92
$196.95K
Mehta Vimal
16 Dec 2022
CEO and President
Sold after exercise
20,113
$19.21
$386.37K
Mehta Vimal
15 Dec 2022
CEO and President
Sold after exercise
7,206
$20.19
$145.49K
Mehta Vimal
15 Dec 2022
CEO and President
Sold after exercise
22,794
$19.86
$452.69K
Nandabalan Krishnan
11 Nov 2022
Director
Sold after exercise
32,550
$15.00
$488.25K
Nandabalan Krishnan
10 Nov 2022
Director
Sold after exercise
27,450
$15.00
$411.75K
O'Neill Vincent
17 Feb 2021
Chief Medical Officer
Sold after exercise
600
$57.17
$34.30K
O'Neill Vincent
17 Feb 2021
Chief Medical Officer
Sold after exercise
9,573
$56.60
$541.83K
O'Neill Vincent
17 Feb 2021
Chief Medical Officer
Sold after exercise
6,872
$55.55
$381.74K
O'Neill Vincent
17 Feb 2021
Chief Medical Officer
Sold after exercise
5,655
$54.45
$307.91K
O'Neill Vincent
17 Feb 2021
Chief Medical Officer
Sold after exercise
2,300
$53.77
$123.67K
Steinhart Richard I
1 Feb 2021
Chief Financial Officer
Sold after exercise
3,750
$48.15
$180.56K
Yocca Frank
25 Jan 2021
Chief Scientific Officer
Sold after exercise
4,107
$49.35
$202.68K
Yocca Frank
25 Jan 2021
Chief Scientific Officer
Sold after exercise
6,521
$48.39
$315.55K
Yocca Frank
25 Jan 2021
Chief Scientific Officer
Sold after exercise
3,472
$47.62
$165.34K
Yocca Frank
25 Jan 2021
Chief Scientific Officer
Sold after exercise
900
$46.94
$42.25K
O'Neill Vincent
19 Jan 2021
Chief Medical Officer
Sold after exercise
1,377
$52.45
$72.22K
O'Neill Vincent
19 Jan 2021
Chief Medical Officer
Sold after exercise
1,500
$51.45
$77.18K
O'Neill Vincent
19 Jan 2021
Chief Medical Officer
Sold after exercise
2,700
$50.38
$136.03K
O'Neill Vincent
19 Jan 2021
Chief Medical Officer
Sold after exercise
12,665
$49.27
$624.00K
O'Neill Vincent
19 Jan 2021
Chief Medical Officer
Sold after exercise
6,758
$48.43
$327.29K
O'Neill Vincent
28 Dec 2020
Chief Medical Officer
Sold after exercise
1,353
$53.54
$72.44K
O'Neill Vincent
28 Dec 2020
Chief Medical Officer
Sold after exercise
3,951
$52.68
$208.14K
O'Neill Vincent
28 Dec 2020
Chief Medical Officer
Sold after exercise
5,727
$51.75
$296.37K
O'Neill Vincent
28 Dec 2020
Chief Medical Officer
Sold after exercise
13,969
$50.77
$709.21K

What was left out

Form 4 filings counted 230
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 41
Sales straight out of an exercise 42
Sales at will 23
Transactions with no price 3
Shares from compensation/vesting 2,968,409
Sales filed before the plan box existed 18
History held since 13 Mar 2018